Lianluo Smart (Lianluo Smart) EBIT : $-2.98 Mil (TTM As of Dec. 2020)

View and export this data going back to 2010. Start your Free Trial

What is Lianluo Smart EBIT?

Lianluo Smart's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2020 was $-1.28 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2020 was $-2.98 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Lianluo Smart's annualized ROC % for the quarter that ended in Dec. 2020 was -103.62%. Lianluo Smart's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -165.59%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Lianluo Smart's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2020 was -6.69%.

Lianluo Smart EBIT Historical Data

The historical data trend for Lianluo Smart's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lianluo Smart EBIT Chart

Lianluo Smart Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

EBIT

Get a 7-Day Free Trial

-9.08

-5.06

-5.98

-3.80

-2.98

Lianluo Smart Semi-Annual Data
	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
EBIT	Get a 7-Day Free Trial															-2.54	-3.30	-0.50	-1.70	-1.28

Competitive Comparison of Lianluo Smart's EBIT

For the Medical Devices subindustry, Lianluo Smart's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lianluo Smart's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Lianluo Smart's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Lianluo Smart's EV-to-EBIT falls into.

Lianluo Smart EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2020 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.98 Mil.

Lianluo Smart (NAS:LLIT) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Lianluo Smart's annualized ROC % for the quarter that ended in Dec. 2020 is calculated as:

	ROC % (Q: Dec. 2020 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2020 )	+	Invested Capital (Q: Dec. 2020 ))	/ count )
=	-2.922 * ( 1 - 0% )	/	( (2.44	+	3.2)	/ 2 )
=	-2.922	/	2.82
=	-103.62 %

where

	Invested Capital		(Q: Jun. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8.183	-	1.101	-	( 6.683	-	max(0, 3.269	-	7.911	+	6.683	))
=	2.44

	Invested Capital		(Q: Dec. 2020 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6.048	-	0.758	-	( 2.09	-	max(0, 2.717	-	5.973	+	2.09	))
=	3.2

Note: The Operating Income data used here is two times the semi-annual (Dec. 2020) data.

2. Joel Greenblatt's definition of Return on Capital:

Lianluo Smart's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2020 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2020 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2020		Q: Dec. 2020
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-2.56	/	( ( (0.272 + max(-0.303, 0))	+	(0.076 + max(2.744, 0)) )	/	2 )
=	-2.56	/	( ( 0.272	+	2.82 )	/	2 )
=	-2.56	/	1.546
=	-165.59 %

where Working Capital is:

	Working Capital		(Q: Jun. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.092	+	0.813	+	0.032)	-	(1.101	+	0.138	+	0.0010000000000003)
=	-0.303

	Working Capital		(Q: Dec. 2020 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.005	+	0.089	+	3.583)	-	(0.758	+	0.165	+	0.01)
=	2.744

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2020) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Lianluo Smart's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2020 )
	=	-2.975	/	44.453
	=	-6.69 %

Lianluo Smart EBIT Related Terms

Thank you for viewing the detailed overview of Lianluo Smart's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Lianluo Smart (Lianluo Smart) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lianluo Smart Ltd (NAS:LLIT) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 10 Baifuquan Roa, Room 611, 6th Floor, BeiKong Technology Building, Changping District, Beijing, CHN, 102200

Website

http://www.lianluosmart.com

Lianluo Smart Ltd design, develop and market medical products and medical components. The company focuses on the business sectors of; Medical Equipment and the provision of Obstructive Sleep Apnea Syndrome (OSAS) diagnostic services. Its products include wearable sleep respiratory devices, medical devices for cardiopulmonary resuscitation, DHR998 Plus, and others. The company sells its products to distributors, hospitals and physical examination centers, and others. All of its revenue is generated from China.